Charles Gayer owns 0.37% of Biocryst Pharmaceuticals
952,583 shares as of the December 22, 2025 filing, worth $7.4M at the latest close.
BCRX · $2B market capGet an email when Charles Gayer’s stake moves.
Free.
The stake
0.37%
worth $7.4M at the latest close
Stake rank
#1,901
by dollar value of the stake
Last sale
1,404 days ago
Dec 15, 2022
Last buy
889 days ago
May 13, 2024 · $164,100
Charles Gayer owns 0.37% of BIOCRYST PHARMACEUTICALS INC: 952,583 of 255,535,105 shares, worth about $7.4M at the 2026-10-16 close. The stake has moved from 0.12% in 2020 to 0.37% on 2026-07-31, across 1 sale and 1 purchase that moved it since 2016. The last trade that moved it was a discretionary purchase of $164,100 on 2024-05-13.
How the stake is held
as of the Dec 22, 2025 filing
SHARES
OF THE STAKE
COMMON STOCK · stated Dec 22, 2025 · Form 4 ↗
HELD DIRECTLY
952,583
100.0%
THE STAKE
952,583
0.37%